Financials Dr. Martens plc

Equities

DOCS

GB00BL6NGV24

Footwear

Market Closed - London S.E. 11:35:23 2024-05-31 am EDT 5-day change 1st Jan Change
87.4 GBX +4.05% Intraday chart for Dr. Martens plc +1.45% -1.35%

Valuation

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Capitalization 1 4,532 2,388 1,424 840.8 - -
Enterprise Value (EV) 1 4,706 2,554 1,712 844 1,178 1,187
P/E ratio 126 x 13.2 x 11 x 12.5 x 28.4 x 15.3 x
Yield - 2.3% 4.1% 5.86% 3.03% 3.44%
Capitalization / Revenue 5.86 x 2.63 x 1.42 x 0.96 x 1 x 0.94 x
EV / Revenue 6.09 x 2.81 x 1.71 x 0.96 x 1.41 x 1.33 x
EV / EBITDA 21 x 9.71 x 6.99 x 4.27 x 8.15 x 6.21 x
EV / FCF 27.7 x 19.3 x 66.1 x 20.6 x 17 x 22.9 x
FCF Yield 3.61% 5.17% 1.51% 4.84% 5.89% 4.36%
Price to Book 30.1 x 7.3 x 3.52 x 2.14 x 2.21 x 2.03 x
Nbr of stocks (in thousands) 1,000,000 1,000,111 1,000,770 961,972 - -
Reference price 2 4.532 2.388 1.423 0.8740 0.8740 0.8740
Announcement Date 6/17/21 6/1/22 6/1/23 5/30/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net sales 1 672.2 773 908.3 1,000 877.1 837.4 890.1
EBITDA 1 - 224.2 263 245 197.5 144.6 191
EBIT 1 - 193 229.3 176.2 122.2 67.66 106.9
Operating Margin - 24.97% 25.24% 17.61% 13.93% 8.08% 12.01%
Earnings before Tax (EBT) 1 - 70.9 214.3 159.4 93 37.06 75.87
Net income 1 74.8 35.7 181.2 128.9 69.2 28.29 52.78
Net margin 11.13% 4.62% 19.95% 12.89% 7.89% 3.38% 5.93%
EPS 2 - 0.0360 0.1810 0.1290 0.0700 0.0308 0.0571
Free Cash Flow 1 - 169.8 132.1 25.9 56.47 69.43 51.8
FCF margin - 21.97% 14.54% 2.59% 6.36% 8.29% 5.82%
FCF Conversion (EBITDA) - 75.74% 50.23% 10.57% 28.93% 48.02% 27.12%
FCF Conversion (Net income) - 475.63% 72.9% 20.09% 81.87% 245.48% 98.15%
Dividend per Share 2 - - 0.0550 0.0584 0.0512 0.0265 0.0300
Announcement Date 10/2/20 6/17/21 6/1/22 6/1/23 5/30/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q3
Net sales 1 454.8 369.9 538.4 418.6 581.7 395.8 290 213 481.3 -
EBITDA - 88.8 - 88.8 - 77.6 - - 119.9 -
EBIT - - - - - 40.3 - - - 1.6
Operating Margin - - - - - 10.18% - - - -
Earnings before Tax (EBT) - - - - - 25.8 - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - 0.0190 - - - -
Dividend per Share - - - - - 0.0156 - - - -
Announcement Date 6/17/21 12/9/21 6/1/22 11/24/22 6/1/23 11/30/23 - - 5/30/24 -
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 174 166 288 325 337 346
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 0.7756 x 0.6304 x 1.177 x 1.665 x 2.334 x 1.812 x
Free Cash Flow 1 - 170 132 25.9 56.5 69.4 51.8
ROE (net income / shareholders' equity) - 105% 75.8% 35.2% 17.2% 7.94% 16.2%
ROA (Net income/ Total Assets) - - - - 6.49% 3.02% 5.39%
Assets 1 - - - - 1,063 935.4 979.6
Book Value Per Share 2 - 0.1500 0.3300 0.4000 0.4100 0.4000 0.4300
Cash Flow per Share 2 - 0.1600 0.1800 0.0800 0.1300 0.1500 0.1600
Capex 1 - 18.6 25 51.4 51 47 51.3
Capex / Sales - 2.41% 2.75% 5.14% 5.75% 5.61% 5.77%
Announcement Date 10/2/20 6/17/21 6/1/22 6/1/23 5/30/24 - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
0.874 GBP
Average target price
0.7498 GBP
Spread / Average Target
-14.20%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. Financials Dr. Martens plc